Literature DB >> 53396

Letter: Association between maternal intake of diazepam and oral clefts.

D Aarskog.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 53396     DOI： 10.1016/s0140-6736(75)92153-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

1.  Cleft palate in mice with a targeted mutation in the gamma-aminobutyric acid-producing enzyme glutamic acid decarboxylase 67.

Authors:  B G Condie; G Bain; D I Gottlieb; M R Capecchi
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

Review 2.  Adverse effects of antianxiety drugs.

Authors:  J G Edwards
Journal:  Drugs       Date:  1981-12       Impact factor: 9.546

Review 3.  The risk-benefit ratio of anticonvulsant drugs.

Authors:  M J Eadie
Journal:  Med Toxicol Adverse Drug Exp       Date:  1987 Sep-Oct

Review 4.  Treatment of anxiety during pregnancy: effects of psychotropic drug treatment on the developing fetus.

Authors:  C McGrath; A Buist; T R Norman
Journal:  Drug Saf       Date:  1999-02       Impact factor: 5.606

5.  Impact of physician counseling and perception of teratogenic risks: a survey of 96 nonpregnant women with anxiety.

Authors:  Tiffany Behringer; Bruce L Rollman; Bea Herbeck-Belnap; Patricia R Houck; Sati Mazumdar; Eleanor Bimla Schwarz
Journal:  Prim Care Companion CNS Disord       Date:  2011

Review 6.  Anticonvulsant drugs. An update.

Authors:  M J Eadie
Journal:  Drugs       Date:  1984-04       Impact factor: 9.546

Review 7.  Clinical pharmacokinetics of diazepam.

Authors:  M Mandelli; G Tognoni; S Garattini
Journal:  Clin Pharmacokinet       Date:  1978 Jan-Feb       Impact factor: 6.447

Review 8.  Benzodiazepine poisoning. Clinical and pharmacological considerations and treatment.

Authors:  P Gaudreault; J Guay; R L Thivierge; I Verdy
Journal:  Drug Saf       Date:  1991 Jul-Aug       Impact factor: 5.606

9.  Bypassing Glutamic Acid Decarboxylase 1 (Gad1) Induced Craniofacial Defects with a Photoactivatable Translation Blocker Morpholino.

Authors:  Matthew J O'Connor; Lindsey L Beebe; Davide Deodato; Rebecca E Ball; A Tyler Page; Ariel J VanLeuven; Kyle T Harris; Sungdae Park; Vani Hariharan; James D Lauderdale; Timothy M Dore
Journal:  ACS Chem Neurosci       Date:  2018-09-24       Impact factor: 4.418
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.